The Canadian Federal government’s failure to facilitate research into the potential health issues associated with cannabis consumption. According to Toronto-based
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual
The company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
The application has been submitted in preparation for a review.
The site will be opened by UK cannabis company Eden Pharma.
The paper explores what Cellular Goods refers to as the ‘5 A’s of cannabinoid skincare’.
A new study concludes that conventional pharmaceutical manufacturers may benefit from investing in cannabis markets rather than lobbying against them.
MGC Pharma has carried out a doubleblind, randomised, placebo controlled clinical study investigating the impact of its epilepsy treatment on driving performance.
A team of researchers has used firefly genes to understand cannabis biology.
MGC Pharmaceuticals has collaborated with the National Institute of Biology in Slovenia to carry out a three year pre-clinical in
Open Book Extracts and Biopharmaceutical Research Company will research the full range of cannabinoids.
The FDA’s interest in the treatment as a potential therapy for sleep apnoea is “extremely encouraging”.
The study provides evidence to support the effectiveness of medical cannabis as a treatment for anxiety and depression.
The Canadian company is establishing research company Tetra Bio-Pharma Australia Pty Ltd.
The Spanish pharmaceutical company has said the approval marks a significant milestone for the advancement of its pipeline of projects.
Many Canadians have continued to source cannabis from illegal sources despite legalisation, new research finds.
Promising results reported from studies testing the efficacy of its lead compound.
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
We won’t spam you
